ArticleRevista brasileira de hematologia e hemoterapia

Molecular response to imatinib mesylate of Brazilian patients with chronic myeloid leukemia.

Ana Lucia Vieira-Mion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.